These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

953 related items for PubMed ID: 9421286

  • 1. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK, Drew GM.
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [Abstract] [Full Text] [Related]

  • 2. The antihypertensive profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential homeostatic compensatory mechanisms in renal hypertensive rats.
    Anderson IK, Drew GM.
    Br J Pharmacol; 1998 Nov; 125(6):1236-46. PubMed ID: 9863652
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 4. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS, Clark KL, Johns EJ, Drew GM.
    Br J Pharmacol; 1998 Aug 15; 124(7):1467-74. PubMed ID: 9723960
    [Abstract] [Full Text] [Related]

  • 5. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD, Friberg P, Adams MA.
    J Hypertens; 1996 Aug 15; 14(8):975-81. PubMed ID: 8884552
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.
    Hilditch A, Hunt AA, Travers A, Polley J, Drew GM, Middlemiss D, Judd DB, Ross BC, Robertson MJ.
    J Pharmacol Exp Ther; 1995 Feb 15; 272(2):750-7. PubMed ID: 7853190
    [Abstract] [Full Text] [Related]

  • 7. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H, Nakagawa Y, Miki S, Shimizu T, Yoshimura A, Inoue R, Asayama J, Kobara M, Nakata T.
    Hypertens Res; 2005 Aug 15; 28(8):689-700. PubMed ID: 16392774
    [Abstract] [Full Text] [Related]

  • 8. Androgenic maintenance of the rat erectile response via a non-nitric-oxide-dependent pathway.
    Reilly CM, Lewis RW, Stopper VS, Mills TM.
    J Androl; 1997 Aug 15; 18(6):588-94. PubMed ID: 9432131
    [Abstract] [Full Text] [Related]

  • 9. Further investigations into the mechanism of the antihypertensive activity of the angiotensin AT1 receptor antagonist, GR138950.
    Hilditch A, Prior HM, Drew GM.
    Br J Pharmacol; 1996 Jun 15; 118(3):711-9. PubMed ID: 8762098
    [Abstract] [Full Text] [Related]

  • 10. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O, Gaudet E, Blanc J, Ponchon P, Elghozi JL.
    Arch Mal Coeur Vaiss; 1996 Aug 15; 89(8):1013-7. PubMed ID: 8949370
    [Abstract] [Full Text] [Related]

  • 11. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA, Paffaro VA, Pauli JR, da Silva GH, Saad MJ, Salgado I, da Cruz-Höfling MA, Hyslop S.
    Cell Tissue Res; 2007 Jul 15; 329(1):45-58. PubMed ID: 17436021
    [Abstract] [Full Text] [Related]

  • 12. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J, Ortiz MC, O'Valle F, Alcaraz A, Navarro EG, Vargas F, Evangelista S, Atucha NM.
    Clin Sci (Lond); 2006 Feb 15; 110(2):227-33. PubMed ID: 16197366
    [Abstract] [Full Text] [Related]

  • 13. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan 15; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 14. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
    Klein T, Eltze M, Grebe T, Hatzelmann A, Kömhoff M.
    Cardiovasc Res; 2007 Jul 15; 75(2):390-7. PubMed ID: 17383621
    [Abstract] [Full Text] [Related]

  • 15. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N, Vuolteenaho O, Tikkanen I.
    J Renin Angiotensin Aldosterone Syst; 2001 Dec 15; 2(4):233-9. PubMed ID: 11881129
    [Abstract] [Full Text] [Related]

  • 16. Effect of NG-nitro-L-arginine methyl ester, the nitric oxide synthase inhibitor, on duodenal alkaline secretion and mepirizole-induced duodenal lesions in rats.
    Takeuchi K, Takehara K, Kato S.
    J Clin Gastroenterol; 1995 Dec 15; 21 Suppl 1():S66-72. PubMed ID: 8774993
    [Abstract] [Full Text] [Related]

  • 17. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X, Matavelli LC, Ono H, Frohlich ED.
    Am J Physiol Renal Physiol; 2005 Oct 15; 289(4):F871-9. PubMed ID: 15900021
    [Abstract] [Full Text] [Related]

  • 18. Effects of nitric oxide synthase inhibition on angiotensin receptors and metabolism in the pregnant hypertensive rat.
    Yang Y, Macdonald GJ, Duggan KA.
    Clin Sci (Lond); 2001 Mar 15; 100(3):319-26. PubMed ID: 11222119
    [Abstract] [Full Text] [Related]

  • 19. Nitric oxide modulates air embolism-induced lung injury in rats with normotension and hypertension.
    Liu YC, Kao SJ, Chuang IC, Chen HI.
    Clin Exp Pharmacol Physiol; 2007 Nov 15; 34(11):1173-80. PubMed ID: 17880373
    [Abstract] [Full Text] [Related]

  • 20. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats.
    Ferreira-Melo SE, Yugar-Toledo JC, Coelho OR, De Luca IM, Tanus-Santos JE, Hyslop S, Irigoyen MC, Moreno H.
    Eur J Pharmacol; 2006 Aug 07; 542(1-3):141-7. PubMed ID: 16806160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.